Guangdong Biolight Meditech Co., Ltd.

SZSE:300246 Stock Report

Market Cap: CN¥1.9b

Guangdong Biolight Meditech Past Earnings Performance

Past criteria checks 0/6

Guangdong Biolight Meditech's earnings have been declining at an average annual rate of -32.1%, while the Medical Equipment industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 6.2% per year.

Key information

-32.1%

Earnings growth rate

-33.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate6.2%
Return on equity-6.1%
Net Margin-7.9%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise

Mar 08
There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise

Revenue & Expenses Breakdown
Beta

How Guangdong Biolight Meditech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300246 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,116-8924379
31 Dec 231,194-6526286
30 Sep 231,2677628188
30 Jun 231,2917427988
31 Mar 231,2363528694
01 Jan 231,1842227088
30 Sep 221,176525888
30 Jun 221,1421825085
31 Mar 221,1405322678
01 Jan 221,0916420574
30 Sep 211,07810113968
30 Jun 211,12615913564
31 Mar 211,41633016163
31 Dec 201,39634615957
30 Sep 201,31832421653
30 Jun 201,21927720751
31 Mar 208588918446
31 Dec 198266518645
30 Sep 198267017246
30 Jun 198095818137
31 Mar 198186117842
31 Dec 188136417342
30 Sep 187915117735
30 Jun 187785315053
31 Mar 187395914938
31 Dec 177115815030
30 Sep 176987215620
30 Jun 17649761660
31 Mar 17621701600
31 Dec 16594671540
30 Sep 16541491370
30 Jun 16508451330
31 Mar 16437311240
31 Dec 15381241160
30 Sep 15347371070
30 Jun 15302271000
31 Mar 1530233950
31 Dec 1428934940
30 Sep 1425825950
30 Jun 1424928900
31 Mar 1424831870
31 Dec 1323529820
30 Sep 1323238730
30 Jun 1322539680

Quality Earnings: 300246 is currently unprofitable.

Growing Profit Margin: 300246 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300246 is unprofitable, and losses have increased over the past 5 years at a rate of 32.1% per year.

Accelerating Growth: Unable to compare 300246's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300246 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.5%).


Return on Equity

High ROE: 300246 has a negative Return on Equity (-6.12%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.